<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">The pandemic of coronavirus disease 2019 (COVID-19) has been tremendously impacting the entire world since December 2019. COVID-19 was first reported to affect the respiratory tract and spread from person to person by respiratory droplets; therefore, pulmonologists as well as critical care physicians have been the leading force to counteract this public health crisis. The evidence of digestive system involvement in COVID-19 was first reported by a group in China.
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref> There are increasing data showing that the gastrointestinal (GI) tract and liver might also represent target organs of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), and that infected patients could have corresponding organ damage and symptoms. More important, the evidence of SARS-CoV-2 detection in patient stool and the tentative fecal–oral route transmission have raised great concern and posed a challenge for control and prevention of COVID-19.
 <xref rid="bib2" ref-type="bibr">
  <sup>2</sup>
 </xref> It is the indispensable duty of our gastroenterologists, as we did in the history of other epidemics, to be armed with knowledge, facts, and skills, and united in the battle against COVID-19. In this concise review, we aim to:
 <list list-type="simple" id="ulist0010">
  <list-item id="u0010">
   <label>•</label>
   <p id="p0015">Provide perspectives about how to respond to COVID-19 from the Chinese Society of Gastroenterology (CSG),</p>
  </list-item>
  <list-item id="u0015">
   <label>•</label>
   <p id="p0020">Summarize disease manifestations or complications relevant to GI and liver involvement, and</p>
  </list-item>
  <list-item id="u0020">
   <label>•</label>
   <p id="p0025">Propose recommendations for next steps regarding our future GI practice and care.</p>
  </list-item>
 </list>
</p>
